Journal of Clinical Oncology, Vol 26, No 17 (June 10), 2008: pp. 2806-2812
© 2008 American Society of Clinical Oncology.
DOI: 10.1200/JCO.2008.16.6702
Pancreatic Cancer Stem Cells
Cheong J. Lee,
Joseph Dosch,
Diane M. Simeone
From the Departments of Surgery, Internal Medicine, and Molecular and Integrative Physiology, University of Michigan, Ann Arbor, MI
Corresponding author: Diane M. Simeone, MD, Surgery and Molecular and Integrative Physiology, TC 2210B, Box 5343, University of Michigan Medical Center, 1500 E Medical Center Dr, Ann Arbor, MI 48109; e-mail: simeone{at}umich.edu
Cellular heterogeneity in cancer was observed decades ago by studies in mice which showed that distinct subpopulations of cells within a tumor mass are capable of driving tumorigenesis. Conceptualized from this finding was the stem-cell hypothesis for cancer, which suggests that only a specific subset of cancer cells within each tumor is responsible for tumor initiation and propagation, termed tumor initiating cells or cancer stem cells (CSCs). Recent data has been provided to support the existence of CSCs in human blood cell–derived cancers and solid organ tumors of the breast, brain, prostate, colon, and skin. Study of human pancreatic cancers has also revealed a specific subpopulation of cancer cells that possess the characteristics of CSCs. These pancreatic cancer stem cells express the cell surface markers CD44, CD24, and epithelial-specific antigen, and represent 0.5% to 1.0% of all pancreatic cancer cells. Along with the properties of self-renewal and multilineage differentiation, pancreatic CSCs display upregulation of important developmental genes that maintain self-renewal in normal stem cells, including Sonic hedgehog (SHH) and BMI-1. Signaling cascades that are integral in tumor metastasis are also upregulated in the pancreatic CSC. Understanding the biologic behavior and the molecular pathways that regulate growth, survival, and metastasis of pancreatic CSCs will help to identify novel therapeutic approaches to treat this dismal disease.
Supported by grants provided by the Lustgarten Foundation and Elsa Pardee Foundation (D.M.S.).
Authors disclosures of potential conflicts of interest and author contributions are found at the end of this article.

CiteULike Complore Connotea Del.icio.us Digg Facebook Reddit Technorati Twitter What's this?
This article has been cited by other articles:

|
 |

|
 |
 
S. Balasubramanian, G. Adhikary, and R. L. Eckert
The Bmi-1 polycomb protein antagonizes the (-)-epigallocatechin-3-gallate-dependent suppression of skin cancer cell survival
Carcinogenesis,
March 1, 2010;
31(3):
496 - 503.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Bonnefoix and M. Callanan
Revisiting the Concept of Phenotypically Distinct Malignant Pancreatic Stem-Cell Subsets Based on Limiting Dilution Transplantation Assays
J. Clin. Oncol.,
February 10, 2010;
28(5):
e89 - e90.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Yamazaki, T. Mizukami, K. Takizawa, M. Kuramitsu, H. Momose, A. Masumi, Y. Ami, H. Hasegawa, W. W. Hall, H. Tsujimoto, et al.
Identification of cancer stem cells in a Tax-transgenic (Tax-Tg) mouse model of adult T-cell leukemia/lymphoma
Blood,
September 24, 2009;
114(13):
2709 - 2720.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Zhang, Y. Huang, K. Newman, J. Gu, X. Zhang, H. Wu, M. Zhao, Z. Xianyu, and X. Liu
Reexpression of Human Somatostatin Receptor Gene 2 Gene Mediated by Oncolytic Adenovirus Increases Antitumor Activity of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand against Pancreatic Cancer
Clin. Cancer Res.,
August 15, 2009;
15(16):
5154 - 5160.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Z. Young and A. Bordey
GABA's Control of Stem and Cancer Cell Proliferation in Adult Neural and Peripheral Niches
Physiology,
June 1, 2009;
24(3):
171 - 185.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. C. Kim, F. M. Barlaskar, J. H. Heaton, T. Else, V. R. Kelly, K. T. Krill, J. O. Scheys, D. P. Simon, A. Trovato, W.-H. Yang, et al.
In Search of Adrenocortical Stem and Progenitor Cells
Endocr. Rev.,
May 1, 2009;
30(3):
241 - 263.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. M. Boman and M. S. Wicha
Cancer Stem Cells: A Step Toward the Cure
J. Clin. Oncol.,
June 10, 2008;
26(17):
2795 - 2799.
[Full Text]
[PDF]
|
 |
|
|